Despite the growing body of research demonstrating the associations of LMO1 gene variants with cancer susceptibility, until now, no study had investigated the relationship between LMO1 polymorphisms and Wilms’ tumor risk. This evidence concerns the gene LMO1 and Nephroblastoma.